Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Mol Cancer Res. 2017 Oct 12;16(7):1125–1137. doi: 10.1158/1541-7786.MCR-17-0230

Figure 1.

Figure 1

STMN1 is overexpressed in prostate cancer. STMN1 gene expression from A, microarray, B and C, next-generation RNA sequencing data from benign tissue, prostate carcinoma tissue, and metastatic prostate cancer (MET) tissue from the University of Michigan and TCGA datasets, respectively (B and C). D, qRT-PCR of STMN1 using RNA from benign, prostate cancer, and MET tissues. E, Western blot analysis of the STMN1 protein from prostate tissue extracts using an STMN1-specific antibody. β-Actin was used as a loading control.